Article by Steph Sherer, The Hill
Recently the Drug Enforcement Administration (DEA) quietly removed a report from its website, suggesting that it is finally giving up the false theories that cannabis is a “gateway drug,” or that it causes permanent brain damage or psychosis.
These myths have been at the heart of positions held by marijuana prohibitionists and often served as their platform when voting against medical cannabis legislation.
The good news is that prohibitions that have been holding out support for medical cannabis policy can now let science guide their policy making decisions.
The bad news is unless elected officials read the DEA’s “Denial of Petition to Initiate Proceedings to Reschedule Marijuana (DPR)” issued August 12, 2016, they would still see outdated information being disseminated from the DEA.
Americans for Safe Access (ASA), the organization I founded, is trying to remedy this problem by utilizing our members’ rights under the Information Quality Act (IQA). We’ve had mixed results.
On Dec. 5, 2016, ASA submitted an “IQA Request for Correction of Information Disseminated by DEA Regarding Marijuana (Cannabis)” which cites 25 violations under the IQA. Specifically, the Request states that the DEA website contained inaccurate statements about: (1) the gateway drug hypothesis; (2) irreversible cognitive decline in adults; and (3) cannabis causing psychosis.